Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Camille Lafront"'
Publikováno v:
Data in Brief, Vol 57, Iss , Pp 111053- (2024)
Prostate cancer is a hormone-dependent disease that relies on the androgen signaling, as well as on the estrogen signaling, for growth and survival. To identify the genes regulated by these sex-steroid hormones in the human prostate cancer cell line
Externí odkaz:
https://doaj.org/article/1c9b0d17e88247a6a797311b82c1b3d3
Publikováno v:
Data in Brief, Vol 57, Iss , Pp 110870- (2024)
Sex hormones are necessary for the development and functions of the normal prostate as well as for the initiation and progression of prostate tumors. Indeed, androgens and estrogens can activate their respective nuclear receptors to modulate the expr
Externí odkaz:
https://doaj.org/article/07e531d60ca646a69deda108b8ce90a1
Autor:
Kevin Gonthier, Cindy Weidmann, Line Berthiaume, Cynthia Jobin, Aurélie Lacouture, Camille Lafront, Mario Harvey, Bertrand Neveu, Jérémy Loehr, Alain Bergeron, Yves Fradet, Louis Lacombe, Julie Riopel, Éva Latulippe, Chantal Atallah, Michael Shum, Jean‐Philippe Lambert, Frédéric Pouliot, Martin Pelletier, Étienne Audet‐Walsh
Publikováno v:
Molecular Oncology, Vol 17, Iss 10, Pp 2109-2125 (2023)
The androgen receptor (AR) is an established orchestrator of cell metabolism in prostate cancer (PCa), notably by inducing an oxidative mitochondrial program. Intriguingly, AR regulates cytoplasmic isocitrate dehydrogenase 1 (IDH1), but not its mitoc
Externí odkaz:
https://doaj.org/article/b60b3bf0f71f4ae9996565ed221a4aac
Autor:
null Kevin Gonthier, null Cindy Weidmann, null Line Berthiaume, null Cynthia Jobin, null Aurélie Lacouture, null Camille Lafront, null Mario Harvey, null Bertrand Neveu, null Jérémy Loehr, null Alain Bergeron, null Yves Fradet, null Louis Lacombe, null Julie Riopel, null Éva Latulippe, null Chantal Atallah, null Michael Shum, null Jean‐Philippe Lambert, null Frédéric Pouliot, null Martin Pelletier, null Étienne Audet‐Walsh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ddf24a28337848105407f15371b6843
https://doi.org/10.1002/1878-0261.13441/v2/response1
https://doi.org/10.1002/1878-0261.13441/v2/response1
Autor:
Lucas Germain, Camille Lafront, Virginie Paquette, Bertrand Neveu, Jean-Sébastien Paquette, Frédéric Pouliot, Étienne Audet-Walsh
Publikováno v:
Nature Reviews Urology.
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Scientific Reports
Scientific Reports
The estrogen signaling pathway has been reported to modulate prostate cancer (PCa) progression through the activity of estrogen receptors α and β (ERα and ERβ). Given that selective estrogen receptor modulators (SERMs) are used to treat breast ca
Autor:
Charles Joly-Beauparlant, Arnaud Droit, Martin Pelletier, Camille Lafront, Cindy Weidmann, Virginie Paquette, Raghavendra Tejo Karthik Poluri, Étienne Audet-Walsh, Chantal Guillemette, Eric P. Allain
Publikováno v:
Endocrine-related cancer. 28(4)
Prostate cancer (PCa) cells rely on the androgen receptor (AR) signaling axis to reprogram metabolism to sustain aberrant proliferation. Whether additional transcription factors participate to this reprogramming remains mostly unknown. To identify su
Publikováno v:
Environmental Research. 204:112085
Because of their historical mode of action, endocrine-disrupting chemicals (EDCs) are associated with sex-steroid receptors, namely the two estrogen receptors (ERα and ERβ) and the androgen receptor (AR). Broadly, EDCs can modulate sex-steroid rece
Autor:
Cindy Weidmann, Étienne Audet-Walsh, Lucas Germain, Raghavendra Tejo Karthik Poluri, Jolyane Beaudette, Camille Lafront
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 202:105710
The androgen receptor (AR) is a transcription factor that drives prostate cancer (PCa) by modulating the expression of thousands of genes to promote proliferation and survival and to reprogram metabolism. However, how AR activation controls alternati
Autor:
Lucas Germain, Jolyane Beaudette, Cindy Weidmann, Raghavendra Tejo Karthik Poluri, Étienne Audet-Walsh, Camille Lafront
Publikováno v:
Cancer Research. 80:2083-2083
The androgen receptor (AR) is a transcription factor that drives prostate cancer (PCa) by modulating the expression of thousands of genes to promote proliferation and survival and to reprogram metabolism. However, how AR activation affects alternativ